UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin

Journal of cellular and molecular medicine, 2018-04, Vol.22 (4), p.2210-2219

2018

Volltextzugriff (PDF)

Evolution of GAPDH as a druggable target of tumor glycolysis?

Expert opinion on therapeutic targets, 2018-04, Vol.22 (4), p.295-298

Ganapathy-Kanniappan, Shanmugasundaram

2018

Volltextzugriff (PDF)

Tumor glycolysis as a target for cancer therapy: progress and prospects

Molecular cancer, 2013-12, Vol.12 (1), p.152-152

2013

Volltextzugriff (PDF)

PFKP phenotype in lung cancer: prognostic potential and beyond

Molecular biology reports, 2020-10, Vol.47 (10), p.8271-8272

Ganapathy-Kanniappan, Shanmugasundaram

2020

Volltextzugriff (PDF)

pI Determination of Native Proteins In Biological Samples

Current Protocols in Protein Science, 2019-06, Vol.96 (1), p.e85-n/a

Ganapathy‐Kanniappan, Shanmugasundaram

2019

Volltextzugriff (PDF)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy

Frontiers in oncology, 2017-09, Vol.7, p.232-232

Ganapathy-Kanniappan, Shanmugasundaram

2017

Volltextzugriff (PDF)

Augmented Liver Uptake of the Membrane Voltage Sensor Tetraphenylphosphonium Distinguishes Early Fibrosis in a Mouse Model

Frontiers in physiology, 2021-10, Vol.12, p.676722-676722

2021

Volltextzugriff (PDF)

Advances in GAPDH Protein Analysis: A Functional and Biochemical Approach

Ganapathy-Kanniappan, Shanmugasundaram

1st ed. 2017 edition., 2018

Volltextzugriff (PDF)

Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma

Oncotarget, 2012-09, Vol.3 (9), p.940-953

2012

Volltextzugriff (PDF)

Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?

Frontiers in pharmacology, 2017-10, Vol.8, p.732-732

2017

Volltextzugriff (PDF)

Cancer Metabolism: Molecular Targeting and Implications for Therapy

Shanmugasundaram Ganapathy-Kanniappan

2017

Volltextzugriff (PDF)

Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.536-548

2017

Volltextzugriff (PDF)

Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer

Clinical cancer research, 2014-12, Vol.20 (24), p.6406-6417

2014

Volltextzugriff (PDF)

Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Is Pyruvylated during 3-Bromopyruvate Mediated Cancer Cell Death

Anticancer research, 2009-12, Vol.29 (12), p.4909-4918

2009

Volltextzugriff (PDF)

Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype

Critical reviews in biochemistry and molecular biology, 2018-11, Vol.53 (6), p.667-682

Ganapathy-Kanniappan, Shanmugasundaram

2018

Volltextzugriff (PDF)

Preclinical Benefit of Hypoxia-Activated Intraarterial Therapy with Evofosfamide in Liver Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.536-548

2017

Volltextzugriff (PDF)

Isotopic Tracer Techniques in Preclinical Research

Ganapathy-Kanniappan, Shanmugasundaram

1, 2022

Volltextzugriff (PDF)

Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists

Radiology, 2012-03, Vol.262 (3), p.834-845

2012

Volltextzugriff (PDF)

Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities

Biochimica et biophysica acta. Reviews on cancer, 2017-08, Vol.1868 (1), p.212-220

Ganapathy-Kanniappan, Shanmugasundaram

2017

Volltextzugriff (PDF)

Spontaneous Tumor Regression in a Syngeneic Rat Model of Liver Cancer: Implications for Survival Studies

Journal of vascular and interventional radiology, 2012-12, Vol.23 (12), p.1685-1691

2012

Volltextzugriff (PDF)

Rac1 repression reverses chemoresistance by targeting tumor metabolism

Cancer biology & therapy, 2020-10, Vol.21 (10), p.888-890

Ganapathy-Kanniappan, Shanmugasundaram

2020

Volltextzugriff (PDF)

Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer

Targeted oncology, 2013-06, Vol.8 (2), p.145-151

2013

Volltextzugriff (PDF)

GAPDH with NAD+-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer

Biochimica et biophysica acta. General subjects, 2018-12, Vol.1862 (12), p.2555-2563

2018

Volltextzugriff (PDF)

Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting

Anticancer research, 2013-01, Vol.33 (1), p.13-20

2013

Volltextzugriff (PDF)

Taming Tumor Glycolysis and Potential Implications for Immunotherapy

Frontiers in oncology, 2017-03, Vol.7, p.36-36

Ganapathy-Kanniappan, Shanmugasundaram

2017

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Humans
(24)
Animals
(18)
Glycolysis
(16)
Oncology
(16)
Biochemistry & Molecular Biology
(8)
3-Bromopyruvate
(7)
Cancer
(7)
Cancer Metabolism
(7)
Gapdh
(7)
Immunotherapy
(7)
Cell Line, Tumor
(6)
Mice
(6)
Pyruvates - Administration & Dosage
(6)
Adenosine Triphosphate - Metabolism
(5)
Disease Models, Animal
(5)
Pharmacology & Pharmacy
(5)
Antineoplastic Agents - Pharmacology
(4)
Carcinoma, Hepatocellular - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin

Evolution of GAPDH as a druggable target of tumor glycolysis?

Tumor glycolysis as a target for cancer therapy: progress and prospects

PFKP phenotype in lung cancer: prognostic potential and beyond

pI Determination of Native Proteins In Biological Samples

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy

Augmented Liver Uptake of the Membrane Voltage Sensor Tetraphenylphosphonium Distinguishes Early Fibrosis in a Mouse Model

Advances in GAPDH Protein Analysis: A Functional and Biochemical Approach

Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma

Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?

Cancer Metabolism: Molecular Targeting and Implications for Therapy

Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer

Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer

Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Is Pyruvylated during 3-Bromopyruvate Mediated Cancer Cell Death

Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype

Preclinical Benefit of Hypoxia-Activated Intraarterial Therapy with Evofosfamide in Liver Cancer

Isotopic Tracer Techniques in Preclinical Research

Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists

Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities

Spontaneous Tumor Regression in a Syngeneic Rat Model of Liver Cancer: Implications for Survival Studies

Rac1 repression reverses chemoresistance by targeting tumor metabolism

Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer

GAPDH with NAD+-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer

Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting

Taming Tumor Glycolysis and Potential Implications for Immunotherapy

Suchergebnisse filtern